These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21189220)

  • 1. Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.
    Denis GV
    Discov Med; 2010 Dec; 10(55):489-99. PubMed ID: 21189220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes.
    Wang F; Deeney JT; Denis GV
    Vitam Horm; 2013; 91():49-75. PubMed ID: 23374712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brd2 disruption in mice causes severe obesity without Type 2 diabetes.
    Wang F; Liu H; Blanton WP; Belkina A; Lebrasseur NK; Denis GV
    Biochem J; 2009 Dec; 425(1):71-83. PubMed ID: 19883376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BET domain co-regulators in obesity, inflammation and cancer.
    Belkina AC; Denis GV
    Nat Rev Cancer; 2012 Jun; 12(7):465-77. PubMed ID: 22722403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Roles of BRD7 in Pathophysiology.
    Park SW; Lee JM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological function and histone recognition of family IV bromodomain-containing proteins.
    Lloyd JT; Glass KC
    J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between epigenetic regulation, dietary habits, and the developmental origins of health and disease theory.
    Mochizuki K; Hariya N; Honma K; Goda T
    Congenit Anom (Kyoto); 2017 Nov; 57(6):184-190. PubMed ID: 28169463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.
    Nicholas DA; Andrieu G; Strissel KJ; Nikolajczyk BS; Denis GV
    Cell Mol Life Sci; 2017 Jan; 74(2):231-243. PubMed ID: 27491296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.
    Peng C; Zhou J; Liu HY; Zhou M; Wang LL; Zhang QH; Yang YX; Xiong W; Shen SR; Li XL; Li GY
    J Cell Biochem; 2006 Mar; 97(4):882-92. PubMed ID: 16265664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
    Taniguchi Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.
    Denis GV; Nikolajczyk BS; Schnitzler GR
    FEBS Lett; 2010 Aug; 584(15):3260-8. PubMed ID: 20493850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury.
    Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK
    Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naphthyridines as novel BET family bromodomain inhibitors.
    Mirguet O; Lamotte Y; Chung CW; Bamborough P; Delannée D; Bouillot A; Gellibert F; Krysa G; Lewis A; Witherington J; Huet P; Dudit Y; Trottet L; Nicodeme E
    ChemMedChem; 2014 Mar; 9(3):580-9. PubMed ID: 24000170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The exploitation of FRET probes to track bromodomain/histone interactions in cells for bromodomain inhibitors.
    Sasaki K; Yoshida M
    Drug Discov Today Technol; 2016 Mar; 19():51-56. PubMed ID: 27769358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
    Singh M; Popowicz GM; Krajewski M; Holak TA
    Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic processing in cardiometabolic disease.
    Costantino S; Mohammed SA; Ambrosini S; Paneni F
    Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BET Bromodomain as a Target of Epigenetic Therapy.
    Noguchi-Yachide T
    Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
    Longo M; Raciti GA; Zatterale F; Parrillo L; Desiderio A; Spinelli R; Hammarstedt A; Hedjazifar S; Hoffmann JM; Nigro C; Mirra P; Fiory F; Formisano P; Miele C; Smith U; Beguinot F
    Diabetologia; 2018 Feb; 61(2):369-380. PubMed ID: 29067487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes.
    Xiao Y; Liang L; Huang M; Qiu Q; Zeng S; Shi M; Zou Y; Ye Y; Yang X; Xu H
    Rheumatology (Oxford); 2016 Jan; 55(1):173-84. PubMed ID: 26324948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300.
    Ragvin A; Valvatne H; Erdal S; Arskog V; Tufteland KR; Breen K; ØYan AM; Eberharter A; Gibson TJ; Becker PB; Aasland R
    J Mol Biol; 2004 Apr; 337(4):773-88. PubMed ID: 15033350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.